Studying Organoids: Reagents for Characterization, Differentiation, and Detection

Organoid research has grown substantially over the past decade and a half. What started with self-organizing intestinal epithelium in basement membrane extract has expanded into a platform used across cancer biology, infectious disease, developmental biology, and drug discovery. Patient-derived organoids now appear in investigational new drug (IND) applications. With the expansion of organoid applications, the conversations are now about how to validate them rigorously, scale them reproducibly, and extract high-quality data from them.

As organoid applications continue to expand, reliable characterization strategies have become increasingly important. Researchers commonly assess stemness, proliferation, differentiation, viability, and functional responses using a combination of protein detection, imaging, and biochemical assays to establish that organoids are behaving as expected. Vector Laboratories has reagents for the research applications where organoids are being used, including solutions to the detection challenges that come with working in three dimensions.

Detection Applications in Organoids

Stemness and Organoid Maintenance

Confirming that an organoid retains a functional stem cell compartment is a routine quality check and, in some experimental designs, a primary endpoint. Lgr5 is the canonical intestinal stem cell marker; SOX2, OCT4/POU5F1, and NANOG cover pluripotent and neural stem cell contexts. LSBio, a Vector Laboratories company, carries antibodies against each of these targets for IHC and IF applications, along with ELISA kits for secreted pathway mediators including Wnt3a and FGF2.

On the protein side, Wnt3a, R-Spondin-1, and Noggin are the growth factors that appear most commonly in intestinal organoid media formulations; LSBio recombinant proteins for all three are available in multiple formats. For a full list of stemness-related antibodies, ELISA kits, and proteins, see the quick reference table at the end of this post.

Proliferation and Cell Viability

Proliferation and apoptosis readouts are used both for routine organoid health monitoring and as endpoints in drug response experiments. Ki-67 and PCNA are the standard IHC proliferation markers, and cleaved caspase-3 is an apoptosis indicator. For quantitative measurements from organoid lysates or conditioned media, LSBio offers caspase-3 ELISA kits and an LDH cytotoxicity assay. Recombinant EGF and HGF support epithelial growth in culture and can also serve as positive controls or stimulation reagents in functional assays.

Epithelial Identity and Lineage Differentiation

Assessing differentiation in epithelial organoids typically involves confirming the presence of lineage-specific markers alongside broader epithelial identity markers. E-cadherin and EpCAM are standard epithelial markers; MUC2 marks goblet cells in intestinal organoids; vimentin is used to track epithelial-to-mesenchymal transition in cancer organoid models. LSBio antibodies for each of these targets are validated for IHC and IF, with ELISA kits available for E-cadherin and MUC1 to support quantitative measurements from culture supernatants or lysates.

For directed differentiation experiments, recombinant BMP4 and Activin A are commonly used to drive endodermal lineage commitment; both are available through LSBio.

Neural Organoid Development

Cerebral and neural organoids are used to study neurodevelopment, neurological disease modeling, and drug interactions with CNS tissue. Standard marker panels include TUJ1 (beta-III tubulin) for early neuronal identity, MAP2 for mature neurons, GFAP for astrocytes, and Nestin for neural progenitors. LSBio carries antibodies against each of these targets. BDNF and NGF are the neurotrophic factors most commonly measured as secreted readouts of organoid maturation; ELISA kits for both are available, as are the recombinant proteins themselves for supplementing neural organoid media or running stimulation experiments.

Infection and Inflammatory Response Modeling

Respiratory and intestinal organoids have been used to model viral infection because they express relevant entry receptors and respond to infection with measurable innate immune outputs. ACE2 and TMPRSS2 are the primary entry factors in SARS-CoV-2 work; LSBio antibodies for both are available for IHC-based localization and expression analysis. On the response side, IL-6, TNF-alpha, and IFN-beta are among the cytokines most commonly measured. Our ELISA kits for all three targets provide quantitative readouts using optimized protocol for reproducible data collection. Recombinant ACE2, IL-6, and TNF-alpha proteins are also available for binding studies and stimulation controls.

Detection Challenges in Three-Dimensional Culture

The biological advantages of organoids come with practical complications for detection and imaging. A few issues come up consistently enough to plan for.

Reagent Quality and Endotoxin Content

Organoids used to model inflammatory or immune responses can be sensitive to endotoxin contamination in ways that standard 2D cultures are not. Low-level endotoxin in growth factors, recombinant proteins, or antibody preparations can activate innate immune signaling and confound cytokine readouts. LSBio recombinant proteins are produced with endotoxin specifications stated in product documentation, and Vector Laboraotries custom services can accommodate specific endotoxin requirements. Absolute Antibody recombinant antibodies are produced under conditions designed to meet low-endotoxin requirements, which is particularly relevant for the VivopureX™ line intended for functionally sensitive in vivo and ex vivo applications.

Antibody Format Flexibility for Specialized Assays

Standard commercial antibodies are available in full-length IgG, which covers most IHC and IF applications. Some organoid assay designs call for formats that are not available off the shelf: Fc-silent variants to avoid activating Fc receptors on immune cells in co-culture, bispecific constructs for engaging two targets simultaneously, formats like fragments for altered penetration in 3D models, or custom species and isotype conversions for mixed-species experiments. Absolute Antibody’s custom services cover antibody engineering into more than 200 formats, humanization with manufacturability and scalability built in, and more.

Organoid systems have become powerful tools for studying development, disease biology, host-pathogen interactions, and therapeutic responses.

Through antibodies, ELISA kits, recombinant proteins, and specialized antibody engineering capabilities, Vector Laboratories and its affiliated companies provide reagents designed to support organoid workflows from culture optimization through downstream analysis. These tools can help researchers generate reproducible, biologically meaningful data while addressing the unique challenges associated with three-dimensional cell culture models.

Quick Reference: LSBio Reagents by Application Category

The tables below list representative examples. Full catalogs for each category are searchable at Lsbio.com.

Stemness and Organoid Maintenance

Proliferation and Cell Viability

Epithelial Identity and Lineage Differentiation

Neural Organoid Development

Infection and Inflammatory Response Modeling

Antibodies, ELISA kits, and recombinant proteins from LSBio, a Vector Laboratories company: LSBio.com

Absolute Antibody recombinant formats and reformatting services: AbsoluteAntibody.com

Explore Vector Laboratories' suite of immunodetection antibodies and reagents:

*Terms and conditions: Valid for U.S. direct customers only and for LSBio products only. Cannot be combined with any other promotions or discounts. Apply promo code LSBIO20 at checkout — please note that your cart total will not reflect the discounted price, but the 20% savings will be applied to your final credit card charge or institutional purchase order. To place an order, visit our website LSBio.com, email customerservice@vectorlabs.com, or call (800) 227-6666 / (650) 697-3600. Promotion valid on orders placed no later than September 30, 2026, at 11:59 PM PT.